Last €3.83 EUR
Change Today -0.003 / -0.08%
Volume 310.4K
As of 3:35 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jon D. Levine M.D., Ph.D.

Former Member of Scientific Advisory Board, Evotec AG
AgeTotal Calculated CompensationThis person is connected to 39 board members in 3 different organizations across 4 different industries.

See Board Relationships
----

Background*

Dr. Jon D. Levine M.D., Ph.D. is the Professor of Internal Medicine, Divisions of Rheumatology and Clinical Pharmacology and a Director of the NIH Pain Center at the University of California, San Francisco. Dr. Levine is an inventor of REN-213. He serves as a Member of the Medical and Scientific Review Board at Evotec (US), Inc. (alternative name Renovis Inc.). He serves as a Member of Scientific Advisory Board at Trigemina, Inc. Dr. Levine serves as the Member of Scientific ...

Read Full Background

Corporate Headquarters*

Manfred Eigen Campus
Hamburg, Hamburg 22419

Germany

Phone: 49 4056 0810
Fax: 49 405 608 1222

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1972
Yale University
MA
University of Michigan
BS 1966
University of Michigan
MD 1978
University of California-San Francisco

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EVT:GR €3.83 EUR -0.003

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$552.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EVOTEC AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.